Recombinant Human Oligodendrocyte myelin glycoprotein (His tag C-Terminus)
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant Human Oligodendrocyte myelin glycoprotein (His tag C-Terminus) is a Human Full Length protein, in the 25 to 417 aa range, expressed in Baculovirus infected insect cells, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE.
대체 명칭 보기
OMGP, OMG, Oligodendrocyte-myelin glycoprotein
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human Oligodendrocyte myelin glycoprotein (His tag C-Terminus) (AB219462)
15% SDS-PAGE analysis of 3 μg ab219462.
Molecular Weight : 50-100 kDa (SDS–PAGE under reducing conditions).
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
Purification 테크닉
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OMGP plays an essential role in the CNS where it interacts with other structural components to maintain myelin integrity. OMGP is not a component of a larger complex but works closely with other myelin proteins such as myelin basic protein. It also inhibits neurite outgrowth helping regulate neural plasticity and potentially preventing improper nerve regeneration in mature central nervous systems.
Pathways
Research recognized OMGP as a contributor in the Nogo receptor (NgR) signaling pathway influencing the inhibition of axonal growth. Within this pathway OMGP associates with other proteins like Nogo-A and the receptor NgR1 regulating neuronal growth by binding to these proteins and suppressing neurite outgrowth. This interaction is important in maintaining the structural arrangement of the CNS and modulating its repair mechanisms.
일반 정보
기능
Cell adhesion molecule contributing to the interactive process required for myelination in the central nervous system.
Post-translational modifications
O-glycosylated in its Ser/Thr-rich repeat domain.
타겟 정보
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com